APA (7th ed.) Citation

M, P., MCH, L., ND, J., SH, C., N, A., KG, S., . . . T, B. (2026). Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial. Diabetes care, 49(6), e88. https://doi.org/10.2337/dca26-0020

Chicago Style (17th ed.) Citation

M, Pareek, et al. "Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial." Diabetes Care 49, no. 6 (2026): e88. https://doi.org/10.2337/dca26-0020.

MLA (9th ed.) Citation

M, Pareek, et al. "Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial." Diabetes Care, vol. 49, no. 6, 2026, p. e88, https://doi.org/10.2337/dca26-0020.